Minister of Health Regulation

B.C. Reg. 138/2025: Amendments to section 1 of the Drug Schedules (Limits on Sale) Regulation

Made under the Pharmacy Operations and Drug Scheduling Act

How does this rule affect your organization? One Click reads it against your profile and tells you, on Canada Federal Legislative Tracking. See plans →

Get alerted when the next rule lands

New rules land on their own schedule. Pick how you want to hear about them — we email you when one appears.

Publishing to members? Embed a live rule tracker on your own site — the proposed rules in your area and the comment deadlines closing on them, updating themselves. Free, one line of HTML.

The rule, in full

65 words as published, July 29, 2025. View the original →

B.C. Reg. 138/2025, deposited July 17, 2025, under the PHARMACY OPERATIONS AND DRUG SCHEDULING ACT [section 23 (4)]. Ministerial Order M226/2025, dated June 22, 2025. I, Josie Osborne, Minister of Health, order that section 1 of the Drug Schedules (Limits on Sale) Regulation, B.C. Reg. 103/2023, is amended in the table by adding the following items: Drug Dulaglutide Tirzepatide — J. OSBORNE, Minister of Health.